Takeda Pharmaceutical Co. Ltd. - End Period Cash Flow

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "End-Period-Cash-Flow" stands at 1.76 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2024.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.6815 Trillion JPY for the item "End Period Cash Flow" represents an increase of 94.71 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.6815 Trillion JPY for the item "End Period Cash Flow" represents a decrease of -20.67 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 1.76 Trillion JPY for the item "End Period Cash Flow" represents a decrease of -9.17 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -18.43 percent compared to the value the year prior.
The 1 year change in percent is -18.43.
The 3 year change in percent is -41.71.
The 5 year change in percent is -27.50.
The 10 year change in percent is -32.89.

The Serie's long term average value is 2.13 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 17.56 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2013, to it's latest available value, on 09/30/2025, is +222.48%.
The Serie's change in percent from it's maximum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is -41.71%.